Basher, F., Raez, L., Saravia, D., Rodriguez, E., Uba, R., Arora, A., … De Lima Lopes, G. (2021). MA01.07 Prognostic Value of STK11 & KRAS Mutations and irAE Incidence in Response to Immunotherapy in Hispanics: A Multicenter Analysis. Journal of Thoracic Oncology, 16(10), S888–S888. https://doi.org/10.1016/j.jtho.2021.08.110

Basher, F., L. Raez, D. Saravia, E. Rodriguez, R. Uba, A. Arora, J. Ocejo, et al. “MA01.07 Prognostic Value of STK11 & KRAS Mutations and irAE Incidence in Response to Immunotherapy in Hispanics: A Multicenter Analysis.” Journal of Thoracic Oncology 16, no. 10 (October 2021): S888–S888. https://doi.org/10.1016/j.jtho.2021.08.110.

Basher F, Raez L, Saravia D, Rodriguez E, Uba R, Arora A, et al. MA01.07 Prognostic Value of STK11 & KRAS Mutations and irAE Incidence in Response to Immunotherapy in Hispanics: A Multicenter Analysis. Journal of Thoracic Oncology. 2021 Oct;16(10):S888–S888.

Basher, F., et al. “MA01.07 Prognostic Value of STK11 & KRAS Mutations and irAE Incidence in Response to Immunotherapy in Hispanics: A Multicenter Analysis.” Journal of Thoracic Oncology, vol. 16, no. 10, Elsevier BV, Oct. 2021, pp. S888–S888. Crossref, doi:10.1016/j.jtho.2021.08.110.

Basher F, Raez L, Saravia D, Rodriguez E, Uba R, Arora A, Ocejo J, Khan K, Meiyappan K, Dvir K, Fortuna GG, North A, Dumais K, Powery H, Izquierdo P, De Lima Lopes G. MA01.07 Prognostic Value of STK11 & KRAS Mutations and irAE Incidence in Response to Immunotherapy in Hispanics: A Multicenter Analysis. Journal of Thoracic Oncology. Elsevier BV; 2021 Oct;16(10):S888–S888.